Physician profile
Brian Case
NPI 1922294479
$3,151.23
in general payments reported to CMS, 2019-2025
15 companies · $294 in 2025
The $294 reported for 2025 was more than what 82% of Occupational Medicine providers received nationally (typical 2025 total: $53.66).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $178 · 2021: $1,314 · 2022: $279 · 2023: $367 · 2024: $309 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,200.00 | 2021 | |
| Orexo US, INC. | $698.32 | 2019-2025 | Zubsolv |
| Abbvie INC. | $211.28 | 2021-2023 | Vraylar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.61 | 2019 | |
| Corium, LLC | $137.45 | 2022-2023 | Azstarys |
| Allergan, INC. | $136.41 | 2020 | |
| Braeburn INC. | $133.73 | 2024 | Brixadi |
| Novo Nordisk INC | $118.03 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $101.44 | 2022 | |
| Indivior INC. | $97.82 | 2019-2025 | Sublocade |
| Boston Scientific Corporation | $89.04 | 2025 | Emblem Mri S-Icd, Accolade Sr |
| Abbott Laboratories | $25.00 | 2025 | Cardiomems |
| Mdd US Operations, LLC | $23.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.99 | 2022 | |
| Kaleo, INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.